aTyr Pharma, Inc. (ATYR)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.50-1.23%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ATYR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | — | 0.2 | 0.2 | 0.4 | 10.4 | 0.0 | 10.5 | 0.4 | — | — | — | — |
| Operating Expenses & Income | ||||||||||||
| R&D Expenses | 47.1 | 60.2 | 54.4 | 42.3 | 42.8 | 23.3 | 17.3 | 14.0 | 20.4 | 30.1 | 42.8 | 34.5 |
| Operating Income | (63.9) | (77.6) | (67.9) | (54.9) | (46.4) | (34.0) | (15.9) | (23.0) | (32.8) | (47.1) | (57.9) | (47.6) |
| Earnings from Continuing Operations | ||||||||||||
| Other Non-Operating Income / Expenses | 3.0 | 3.5 | 3.9 | 4.5 | 1.1 | 0.2 | (0.3) | (0.8) | (1.7) | (1.1) | — | — |
| EBT, Incl. Unusual Items | — | (74.1) | (64.0) | (50.4) | (45.3) | (33.8) | (16.2) | (23.8) | (34.5) | (48.2) | (57.9) | (48.0) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | (0.0) | (0.0) | (0.0) | — |
| Net Income | ||||||||||||
| Minority Interest | (0.0) | (0.0) | 0.0 | (0.0) | (0.0) | (0.0) | (0.0) | (0.2) | — | — | — | — |
| Net Income | (60.8) | (74.1) | (64.0) | (50.4) | (45.3) | (33.8) | (16.2) | (16.2) | (34.5) | (48.2) | (57.9) | (48.0) |
| Per Share | ||||||||||||
| Basic EPS | (0.62) | (0.80) | (0.86) | (0.94) | (1.60) | (1.77) | (1.77) | — | — | — | — | — |
| Diluted EPS | (0.62) | (0.80) | (0.86) | (0.94) | (1.60) | (1.77) | (1.77) | — | — | — | — | — |
| Basic Weighted Avg Shares | 98.1 | 93.0 | 74.3 | 53.6 | 28.4 | 19.1 | 9.2 | — | — | — | — | — |
| Diluted Weighted Avg Shares | 98.1 | 93.0 | 74.3 | 53.6 | 28.4 | 19.1 | 9.2 | — | — | — | — | — |
| Supplemental | ||||||||||||
| EBITDA | — | (77.0) | (67.2) | (54.3) | (46.2) | (33.5) | (15.3) | (22.3) | (32.1) | (46.4) | (57.0) | (46.7) |
| EBIT | (63.9) | (77.6) | (67.9) | (54.9) | (46.4) | (34.0) | (15.9) | (23.0) | (32.8) | (47.1) | (57.9) | (47.6) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | — | 0.1% | 0.1% | 0.1% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.